Hester Biosciences Ltd
Hester Biosciences Ltd (HESTERBIO) last traded at ₹2,377, a market capitalisation of ₹2,022 crore, on a P/E of 38.1. Over the past 52 weeks the stock has ranged between ₹1,239 and ₹2,684. Hester Biosciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹77 crore and net profit of ₹97 crore. The next scheduled event is an other on 4 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Hester Biosciences Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Hester Biosciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹77 cr, down 8.3% from ₹84 cr a year earlier. Net profit was ₹97 cr, up 470.6% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 84 | 63 | 82 | 84 | 71 | 77 | 100 | 77 |
| Expenses | 65 | 58 | 63 | 61 | 59 | 60 | 66 | 54 |
| Operating profit | 19 | 5 | 19 | 23 | 12 | 18 | 34 | 23 |
| OPM % | 23% | 8% | 23% | 27% | 17% | 23% | 34% | 29% |
| Other income | 3 | 9 | -6 | 3 | 12 | 2 | 2 | 89 |
| Interest | 6 | -4 | 6 | 2 | 2 | 2 | 5 | 3 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 6 | 7 |
| Profit before tax | 12 | 13 | 4 | 20 | 17 | 14 | 25 | 102 |
| Tax % | 29% | 15% | 59% | 14% | 16% | 31% | 34% | 5% |
| Net profit | 8 | 11 | 2 | 17 | 14 | 9 | 17 | 97 |
| EPS (₹) | 9.64 | 13.71 | 1.52 | 19.33 | 16.99 | 10.31 | 18.78 | 114.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Hester Biosciences Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 214 | 235 | 266 | 305 | 311 | 333 | 326 |
| Operating profit | 69 | 60 | 51 | 54 | 62 | 87 | 87 |
| OPM % | 32% | 26% | 19% | 18% | 20% | 26% | 27% |
| Net profit | 35 | 39 | 28 | 21 | 29 | 57 | 137 |
| EPS (₹) | 40.47 | 46.22 | 31.30 | 22.21 | 32.31 | 65.41 | 160.08 |
TTM is the trailing twelve months to the most recent quarter.
Hester Biosciences Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 9%
- 3 Years
- 8%
- TTM
- 4%
- 10 Years
- 11%
- 5 Years
- 8%
- 3 Years
- 26%
- TTM
- 41%
- 10 Years
- 12%
- 5 Years
- 1%
- 3 Years
- 12%
- 1 Year
- 11%
- 10 Years
- 14%
- 5 Years
- 12%
- 3 Years
- 11%
- Last Year
- 16%
Hester Biosciences Ltd shareholding pattern
Promoters held 53.73% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.31% and DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% |
| FIIs | 0.61% | 0.59% | 0.87% | 0.51% | 0.53% | 0.52% | 0.38% | 0.31% |
| DIIs | 0.00% | 0.02% | 0.02% | 0.02% | 0.00% | 0.01% | 0.00% | 0.00% |
| Public | 45.66% | 45.65% | 45.38% | 45.73% | 45.73% | 45.75% | 45.88% | 45.95% |
| No. of shareholders | 11,538 | 11,473 | 11,853 | 11,810 | 12,260 | 12,603 | 12,373 | 11,961 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Hester Biosciences Ltd events
The next scheduled event is an other on 4 Sept 2026.
- OtherReclassification of Promoter Group members to Public shareholders
See the full results calendar for every Indian company reporting in the next 30 days.
Hester Biosciences Ltd corporate filings
- Postal Ballot NoticeAGM/EGMlow impact
Cruxal's analysis: Hester Biosciences Limited has issued a postal ballot notice to seek shareholder approval…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Hester Biosciences Ltd
Cruxal reads every Hester Biosciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.